Autoimmune Movement Disorder Panel, CSF (Change effective as of 4/21/25: Refer to 3018966 in the April Hotline)

Use

This panel is used to evaluate subacute‑onset movement disorders by detecting a range of neuronal autoantibodies in cerebrospinal fluid that are associated with autoimmune movement disorders. Identification of these antibodies can support diagnosis, guide clinical management, and inform evaluation for underlying causes including paraneoplastic syndromes.

Not provided.